Inhibiting SARS‐CoV‐2 infection with lysosomal alkalizers

Understanding the SARS‐CoV‐2 virus’ routes of infection, virus–host–protein interactions, and mechanisms of virus‐induced cytopathic effects will greatly aid in the discovery and design of new therapeutics to treat COVID‐19. Chloroquine and hydroxychloroquine, extensively explored as clinical agents...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:FASEB J
Glavni autori: Gorshkov, Kirill, Chen, Catherine, Bostwick, Robert, Rasmussen, Lynn, Tran, Bruce, Cheng, Yu‐Shan, Xu, Miao, Pradhan, Manisha, Henderson, Mark, Zhu, Wei, Oh, Eunkeu, Susumu, Kimihiro, Wolak, Mason, Shamim, Khalida, Huang, Wenwei, Hu, Xin, Shen, Min, Klumpp‐Thomas, Carleen, Itkin, Zina, Shinn, Paul, de la Torre, Juan Carlos, Simeonov, Anton, Michael, Samuel, Hall, Matthew, Lo, Donald, Zheng, Wei
Format: Artigo
Jezik:Inglês
Izdano: The Federation of American Societies for Experimental Biology 2021
Teme:
Pharmacology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239884/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fasebj.2021.35.S1.02122
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items